Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean aromatase inhibitor?
Displaying drugs 2326 - 2350 of 2437 in total
Ellipticine is a potent antineoplastic agent.
Investigational
Matched Categories: … Enzyme Inhibitors
MK0893 has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.
Investigational
Matched Categories: … Receptors, Glucagon, antagonists & inhibitors
CUDC-101 has been used in trials studying the treatment of Cancer, Tumors, Liver Cancer, Breast Cancer, and Gastric Cancer, among others.
Investigational
Matched Categories: … Histone Deacetylase Inhibitors
Experimental
Matched Categories: … Platelet Aggregation Inhibitors Excl. Heparin …
Experimental
Matched Categories: … Triose-Phosphate Isomerase, antagonists & inhibitors
Sar9, Met (O2)11-Substance P is a neurokinin-1 receptor agonist. It is an analog of the naturally occurring human neuropeptide Substance P, which can be found throughout the body, including in the airways of humans and many other species.
Investigational
Matched Categories: … Receptors, Neurokinin-3, antagonists & inhibitors
Tanzisertib has been used in trials studying the treatment of Fibrosis, Discoid Lupus, Pulmonary Fibrosis, Interstitial Lung Disease, and Lung Diseases, Interstitial, among others.
Investigational
Matched Categories: … JNK Mitogen-Activated Protein Kinases, antagonists & inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors
Omipalisib has been used in trials studying the treatment of CANCER, Solid Tumours, and Idiopathic Pulmonary Fibrosis.
Investigational
Matched Categories: … Phosphatidylinositol 3-Kinases, antagonists & inhibitors
Coagulation factor XIa is under investigation in clinical trial NCT01701947 (HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency).
Investigational
Matched Categories: … Factor XIa, antagonists & inhibitors
Saredutant (SR 48968) is a neurokinin-2 antagonist drug being developed as an antidepressant and anxiolytic by Sanofi-Aventis.
Investigational
Matched Categories: … Receptors, Neurokinin-2, antagonists & inhibitors
Experimental
Matched Categories: … Thyroxine-binding globulin inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors
A strong dicarboxylic acid occurring in many plants and vegetables. It is produced in the body by metabolism of glyoxylic acid or ascorbic acid. It is not metabolized but excreted in the urine. It is used as an analytical reagent and general reducing agent. [PubChem]
Experimental
Matched Categories: … Organic Anion Transporting Polypeptide 2B1 Inhibitors
Cytisine is an alkaloid naturally derived from the Fabaceae family of plants including the genera Laburnum and Cytisus. Recent studies have shown it to be a more effective and significantly more affordable smoking cessation treatment than nicotine replacement therapy. Also known as baptitoxine or sophorine, cytisine has been used as...
Experimental
Matched Categories: … Nicotine, antagonists & inhibitors
Laninamivir octanoate has been used in trials studying the treatment of Asthma.
Investigational
Matched Categories: … Neuraminidase, antagonists & inhibitors
Teneligliptin has been investigated for the treatment of Type 2 Diabetes Mellitus.
Investigational
Matched Categories: … DPP-IV Inhibitors
Y-27632 is an inhibitor of Rho-associated protein kinase. It inhibits calcium sensitization to affect smooth muscle relaxation.
Experimental
Matched Categories: … Enzyme Inhibitors
Experimental
Matched Categories: … Thymidylate Synthase, antagonists & inhibitors
CT-322 is a proprietary Adnectin(TM) protein therapeutic that, in preclinical studies, specifically binds to vascular endothelial growth factor receptor 2 (VEGFR-2), which regulates the primary tumor angiogenesis pathway. As a result, CT-322 blocks all known ligands for VEGFR-2.
Investigational
Matched Categories: … Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
Acetovanillone has been used in trials studying the treatment of Bronchial Asthma and Chronic Obstructive Pulmonary Disease.
Investigational
Matched Categories: … Enzyme Inhibitors
Evogliptin has been used in trials studying the treatment and screening of Osteoporosis, Renal Impairment, Type 2 Diabetes Mellitus, Diabetes Mellitis Type 2, and Diabetes Mellitus, Type 2.
Investigational
Matched Categories: … DPP-IV Inhibitors
Ibipinabant has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.
Investigational
Matched Categories: … Receptor, Cannabinoid, CB1, antagonists & inhibitors
Umifenovir is an indole-based, hydrophobic, dual-acting direct antiviral/host-targeting agent used for the treatment and prophylaxis of influenza and other respiratory infections. It has been in use in Russia for approximately 25 years and in China since 2006. Its invention is credited to a collaboration between Russian scientists from several research...
Investigational
Matched Categories: … UGT1A9 Inhibitors ... UGT2B7 Inhibitors
Regramostim (GM-CSF) is a differentially glycosylated factor produced mainly by activated T cells and macrophages. Endothelial cells and fibroblasts can also produce GM-CSF after exposure to TNF-α, IL-1, IL-2 and IFN-γ. GM-CSF is found associated with extracellular matrix and in membrane-bound formats too. GM-CSF stimulates proliferation, activation and differentiation of...
Investigational
Matched Categories: … Cholinesterase Inhibitors
Displaying drugs 2326 - 2350 of 2437 in total